Perspectives

The key financial decisions and priorities for biotech startups At our latest webinar, Hoffmann & Partner walked founders through what financial infrastructure you actually need…

Bringing a therapeutic innovation to market requires more than great science—it also demands long-term strategic thinking about funding, ownership, IP, future partnerships, and potential exit…

How Novo Nordisk partners with academia, biotech companies and beyond Novo Nordisk began with a one-dollar insulin license. Today, it’s a global giant fighting more…

Navigating US & EU Patent Law for Startups – avoiding the common pitfalls If you want to protect your intellectual property with a patent, you…

Filing intellectual property (IP) on novel targets and epitopes Building a strong IP portfolio is complex, especially when securing patents for novel targets and epitopes.…

What’s the ideal deal structure to secure funding for biotech startups? As the biotech funding environment evolves, particularly in early seed and Series A rounds,…

Transitioning from early- to late-stage development is a pivotal phase for any biotech startup. This journey, often laden with both opportunities and challenges, requires a…

9 tips for scientists who want to become entrepreneurs In our latest event, hosted in Strasbourg and co-organized with KPMG, we explored what it takes…

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch the attention of investors.For biotech…

Insights into Roche's partnering and venture fund strategies In our biotech networking event with Roche, powered by Innosuisse, we explored the path from pioneering scientific…